Cargando…

The biology and role of CD44 in cancer progression: therapeutic implications

CD44, a non-kinase transmembrane glycoprotein, is overexpressed in several cell types including cancer stem cells and frequently shows alternative spliced variants that are thought to play a role in cancer development and progression. Hyaluronan, the main ligand for CD44, binds to and activates CD44...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chen, Zhao, Shujie, Karnad, Anand, Freeman, James W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946470/ https://www.ncbi.nlm.nih.gov/pubmed/29747682 http://dx.doi.org/10.1186/s13045-018-0605-5

Ejemplares similares

Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets
por: Chang, Katherine, et al.
Publicado: (2015)

Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching
por: Chen, Chen, et al.
Publicado: (2022)

CD44 is overexpressed and correlated with tumor progression in gallbladder cancer
por: He, Yuting, et al.
Publicado: (2018)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
por: Wang, Zhe, et al.
Publicado: (2018)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

Proteolytic Processing of CD44 and Its Implications in Cancer
por: Medrano-González, Priscila Anhel, et al.
Publicado: (2021)

Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance
por: Pothuraju, Ramesh, et al.
Publicado: (2020)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

CD44: A Multifunctional Mediator of Cancer Progression
por: Hassn Mesrati, Malak, et al.
Publicado: (2021)

Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Chaudhry, Gul-e-Saba, et al.
Publicado: (2021)

CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
por: Martincuks, Antons, et al.
Publicado: (2020)

CD44 Glycosylation as a Therapeutic Target in Oncology
por: Liao, Chengcheng, et al.
Publicado: (2022)

CD44v6 engages in colorectal cancer progression
por: Ma, Lixin, et al.
Publicado: (2019)

The prognostic value and immunological role of CD44 in pan-cancer study
por: Chen, Shaoyong, et al.
Publicado: (2023)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
por: Zhang, Jun, et al.
Publicado: (2021)

Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications
por: Ju, Huai-Qiang, et al.
Publicado: (2016)

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway
por: Okamoto, Isamu, et al.
Publicado: (2001)

CD44: A metastasis driver and therapeutic target
por: Sottnik, Joseph L., et al.
Publicado: (2016)

CD44 as a tumor biomarker and therapeutic target
por: Xu, Hanxiao, et al.
Publicado: (2020)

SALL4 promotes gastric cancer progression through activating CD44 expression
por: Yuan, X, et al.
Publicado: (2016)

Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer
por: Zhou, Jin-Yong, et al.
Publicado: (2016)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer
por: Jang, Byung Ik, et al.
Publicado: (2011)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

The role of CD44 in epithelial–mesenchymal transition and cancer development
por: Xu, Hanxiao, et al.
Publicado: (2015)

Understanding the role of CD44V6 in ovarian cancer
por: Zhang, Hui-Feng, et al.
Publicado: (2017)

Tumorigenic and Metastatic Role of CD44(−/low)/CD24(−/low) Cells in Luminal Breast Cancer
por: Vikram, Rajeev, et al.
Publicado: (2020)

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
por: Thapa, Ranjeeta, et al.
Publicado: (2016)

Correlation of CD44v6 expression with ovarian cancer progression and recurrence
por: Shi, Jun, et al.
Publicado: (2013)

Structure, function and role of CD44 in neoplasia
por: Mishra, Mithilesh N, et al.
Publicado: (2019)

CD44 Immunoexpression in the Progression of Actinic Keratosis and Cutaneous Squamouscarcinoma
por: MARINESCU, A., et al.
Publicado: (2017)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

The Roles of Hyaluronan/RHAMM/CD44 and Their Respective Interactions along the Insidious Pathways of Fibrosarcoma Progression
por: Nikitovic, Dragana, et al.
Publicado: (2013)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Another Notch in CD44
por: Dove, Alan W.
Publicado: (2001)

Whole-genome approach implicates CD44 in cellular resistance to carboplatin
por: Shukla, Sunita J, et al.
Publicado: (2009)

Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence
por: Molejon, Maria Inés, et al.
Publicado: (2015)

The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
por: Guo, Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l7uo3lvcppfvno67eomhs3sqis